emcdonald on DSK2BSOYB1PROD with NOTICES

Federal Register / Vol. 76, No. 88 / Friday, May 6, 2011 / Notices 26299 

well as one clerical or administrative 

staff member, at $15 per hour, require 

such training, for a total burden of 

39,804 hours (19,902 funeral homes × 2 

hours total per establishment), and 

$925,443 [($35 + $23 + $20 + $15) × c 

hour per employee × 19,902 funeral 

homes]. 

The total labor cost of the three 

disclosure requirements imposed by the 

Funeral Rule is $3,139,620 ($1,343,385 

+ $90,545 + $1,705,690). The total labor 

cost for recordkeeping is $298,530. The 

total labor cost for disclosures, 

recordkeeping, and training is 

$4,363,593 ($3,139,620 for disclosures + 

$298,530 for recordkeeping + $925,443 

for training). 

Capital or other non-labor costs: The 

Rule imposes minimal capital costs and 

no current start-up costs. The Rule first 

took effect in 1984 and the revised Rule 

took effect in 1994, so funeral providers 

should already have in place necessary 

equipment to carry out tasks associated 

with Rule compliance. Moreover, most 

funeral homes already have access, for 

other business purposes, to the ordinary 

office equipment needed for 

compliance, so the Rule likely imposes 

minimal additional capital expense. 

Compliance with the Rule, however, 

does entail some expense to funeral 

providers for printing and duplication 

of required disclosures. Assuming that 

one copy of the GPL is provided to 

consumers for each funeral or cremation 

conducted, at $.25 per copy, as required 

by the Rule,14 this would amount to 

2,436,682 copies per year at a 

cumulative industry cost of $624,171 

(2,436,682 funerals per year15 × $.25 per 

price list). In addition, the funeral 

providers that furnish consumers with 

an SFGSS solely because of the Rule’s 

mandate will incur additional printing 

and copying costs. Assuming that those 

2,587 providers (19,902 funeral 

providers × 13%) use the standard twopage form SFGSS shown in the 

compliance guide, at twenty-five cents 

per copy, at an average of twenty 

funerals per year, the added cost burden 

would be $12,935 (2,587 providers × 20 

funerals per year × $.25). Thus, 

only’’ found in the 2010 NFDA Member 

Compensation Survey. See http://www.nfda.org/ 

news-a-events/all-press-releases/2289-nfdareleases-results-of-2010-member-compensationsurvey.html. Hourly rates were then determined by 

dividing those salaries by an assumed 2,000 hour 

work year, then rounded. 

14 Although copies of the CPL and OBCPL must 

be shown to consumers, the Rule does not require 

that they be given to consumers. Thus, the cost of 

printing a single copy of these two disclosures to 

show consumers is de minimis, and is not included 

in this estimate of printing costs. 

15 See note 2 and accompanying text. 

estimated non-labor costs total 

$637,106. 

Request for Comment 

You can file a comment online or on 

paper. For the Commission to consider 

your comment, we must receive it on or 

before July 5, 2011. Write ‘‘Paperwork 

Comment: FTC File No. P084401’’ on 

your comment. Your comment— 

including your name and your state— 

will be placed on the public record of 

this proceeding, including, to the extent 

practicable, on the public Commission 

Web site, at http://www.ftc.gov/os/ 

publiccomments.shtm. As a matter of 

discretion, the Commission tries to 

remove individuals’ home contact 

information from comments before 

placing them on the Commission Web 

site. 

Because your comment will be made 

public, you are solely responsible for 

making sure that your comment doesn’t 

include any sensitive personal 

information, like anyone’s Social 

Security number, date of birth, driver’s 

license number or other state 

identification number or foreign country 

equivalent, passport number, financial 

account number, or credit or debit card 

number. You are also solely responsible 

for making sure that your comment 

doesn’t include any sensitive health 

information, like medical records or 

other individually identifiable health 

information. In addition, don’t include 

any ‘‘[t]rade secret or any commercial or 

financial information which is obtained 

from any person and which is privileged 

or confidential * * *, ’’ as provided in 

Section 6(f) of the FTC Act, 15 U.S.C. 

46(f), and FTC Rule 4.10(a)(2), 16 CFR 

4.10(a)(2). If you want the Commission 

to give your comment confidential 

treatment, you must file it in paper 

form, with a request for confidential 

treatment, and you have to follow the 

procedure explained in FTC Rule 4.9(c), 

16 CFR 4.9(c). Your comment will be 

kept confidential only if the FTC 

General Counsel, in his or her sole 

discretion, grants your request in 

accordance with the law and the public 

interest. 

Postal mail addressed to the 

Commission is subject to delay due to 

heightened security screening. As a 

result, we encourage you to submit your 

comments online, or to send them to the 

Commission by courier or overnight 

service. To make sure that the 

Commission considers your online 

comment, you must file it at https:// 

ftcpublic.commentworks.com/ftc/ 

funeralrulepra, by following the 

instructions on the web-based form. If 

this Notice appears at http:// 

www.regulations.gov/#!home, you also 

may file a comment through that Web 

site. 

If you file your comment on paper, 

write ‘‘Paperwork Comment: FTC File 

No. P084401’’ on your comment and on 

the envelope, and mail or deliver it to 

the following address: Federal Trade 

Commission, Office of the Secretary, 

Room H–113 (Annex J), 600 

Pennsylvania Avenue, NW., 

Washington, DC 20580. If possible, 

submit your paper comment to the 

Commission by courier or overnight 

service. 

Visit the Commission Web site at 

http://www.ftc.gov to read this Notice 

and the news release describing it. The 

FTC Act and other laws that the 

Commission administers permit the 

collection of public comments to 

consider and use in this proceeding as 

appropriate. The Commission will 

consider all timely and responsive 

public comments that it receives on or 

before July 5, 2011. You can find more 

information, including routine uses 

permitted by the Privacy Act, in the 

Commission’s privacy policy, at http:// 

www.ftc.gov/ftc/privacy.htm. 

The FTC invites comments on: (1) 

Whether the proposed collection of 

information is necessary for the proper 

performance of the functions of the 

agency, including whether the 

information will have practical utility; 

(2) the accuracy of the agency’s estimate 

of the burden of the proposed collection 

of information, including the validity of 

the methodology and assumptions used; 

(3) ways to enhance the quality, utility, 

and clarity of the information to be 

collected; and (4) ways to minimize the 

burden of the collection of information 

on those who are to respond, including 

through the use of appropriate 

automated, electronic, mechanical, or 

other technological collection 

techniques or other forms of information 

technology, e.g., permitting electronic 

submission of responses. 

Willard K. Tom, 

General Counsel. 

[FR Doc. 2011–11053 Filed 5–5–11; 8:45 am] 

BILLING CODE 6750–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Designation of a Class of Employees 

for Addition to the Special Exposure 

Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Department of Health and 

Human Services (HHS). 

ACTION: Notice. 

emcdonald on DSK2BSOYB1PROD with NOTICES

26300 Federal Register / Vol. 76, No. 88 / Friday, May 6, 2011 / Notices 

SUMMARY: HHS gives notice of a 

decision to designate a class of 

employees from the Linde Ceramics 

Plant in Tonawanda, New York, as an 

addition to the Special Exposure Cohort 

(SEC) under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000. On April 21, 2011, 

the Secretary of HHS designated the 

following class of employees as an 

addition to the SEC: 

All Atomic Weapons Employees who 

worked at the Linde Ceramics Plant in 

Tonawanda, New York, from January 1, 1954 

through December 31, 1969, for a number of 

work days aggregating at least 250 work days, 

occurring either solely under this 

employment, or in combination with work 

days within the parameters established for 

one or more other classes of employees in the 

Special Exposure Cohort. 

This designation will become 

effective on May 21, 2011, unless 

Congress provides otherwise prior to the 

effective date. After this effective date, 

HHS will publish a notice in the 

Federal Register reporting the addition 

of this class to the SEC or the result of 

any provision by Congress regarding the 

decision by HHS to add the class to the 

SEC. 

FOR FURTHER INFORMATION CONTACT: 

Stuart L. Hinnefeld, Director, Division 

of Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health (NIOSH), 4676 

Columbia Parkway, MS C–46, 

Cincinnati, OH 45226, Telephone 877– 

222–7570. Information requests can also 

be submitted by e-mail to 

DCAS@CDC.GOV. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 2011–11094 Filed 5–5–11; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the Advisory Committee on 

Blood Safety and Availability 

AGENCY: Department of Health and 

Human Services, Office of the Secretary, 

Office of the Assistant Secretary for 

Health. 

ACTION: Notice. 

SUMMARY: As stipulated by the Federal 

Advisory Committee Act, the U.S. 

Department of Health and Human 

Services (HHS) is hereby giving notice 

that the Advisory Committee on Blood 

Safety and Availability (ACBSA) will 

hold a meeting. The meeting will be 

open to the public. 

DATES: The meeting will take place 

Tuesday, June 7, and Wednesday June 8, 

2011, from 8:30 a.m. to 5 p.m. 

ADDRESSES: National Institute of Health, 

Building 31, Conference Room 6, 

Bethesda, MD 20892. 

FOR FURTHER INFORMATION CONTACT: Mr. 

James Berger, Associate Public Health 

Advisor for Blood, Organ and Tissue 

Safety, Office of the Assistant Secretary 

for Health, Department of Health and 

Human Services, 1101 Wootton 

Parkway, Suite 250, Rockville, MD 

20852, (240) 453–8803, Fax (240) 453– 

8456, e-mail ACBSA@hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

ACBSA shall provide advice to the 

Secretary through the Assistant 

Secretary for Health. The Committee 

shall advise on a range of policy issues 

to include: (1) Definition of public 

health parameters around safety and 

availability of the blood supply and 

blood products, (2) broad public health, 

ethical and legal issues related to 

transfusion, and transplantation safety, 

and (3) the implications for safety and 

availability of various economic factors 

affecting product cost and supply. 

In keeping with its established 

mission, the Committee will also be 

asked to review and provide comments 

to the Department on two World Health 

Assembly (WHA) resolutions related to 

transfusion, and transplantation safety. 

http://apps.who.int/gb/ebwha/pdf_files/ 

WHA63/A63_R22-en.pdf On June 7, 

2011, the Committee will be asked to 

review the WHA 63.22 on human organ 

and tissue transplantation and if 

appropriate, make recommendations on 

areas of enhanced safety. Specifically 

areas of collecting data including 

adverse events and reactions on the 

practices, safety, quality, efficacy, 

epidemiology and ethics of donations 

and transplantation will be considered 

as it relates to safety. Concerns for a 

globally consistent coding system for 

human cells, tissues and organs to 

facilitate national and international 

traceability of materials of human origin 

for transplantation will be solicited. In 

addition, the Committee will be asked 

for comments or recommendations on 

developing and promoting international 

best practices. 

On June 8, 2011, the Committee will 

be asked to review and comment on 

WHA 63.12 regarding the availability, 

safety and quality of blood products. 

http://apps.who.int/gb/ebwha/pdf_files/ 

WHA63/A63_R12-en.pdf Specifically 

the Committee will be asked to review 

the current status of safe and rational 

use of blood products in patient blood 

management and assess the current 

status in the U.S. 

In addition, the Committee will be 

asked to comment on the areas of safety 

and sustainability of providing blood 

and blood products that should be 

addressed by the Committee in future 

meetings. 

The public will have the opportunity 

to present their views to the Committee 

during a public comment session 

scheduled for June 7, 2011. Comments 

will be limited to five minutes per 

speaker and must be pertinent to the 

discussion. Pre-registration is required 

for participation in the public comment 

session. Any member of the public who 

would like to participate in this session 

is encouraged to contact the Executive 

Secretary at his/her earliest convenience 

to register for time (limited to 5 

minutes) and registration must be prior 

to close of business on June 3, 2011. If 

it is not possible to provide 30 copies 

of the material to be distributed, then 

individuals are requested to provide a 

minimum of one (1) copy of the 

document(s) to be distributed prior to 

11:30 a.m. Eastern Daylight Time on 

June 6, 2011. It is also requested that 

any member of the public who wishes 

to provide comments to the Committee 

utilizing electronic data projection to 

submit the necessary material to the 

Executive Secretary prior to the close of 

business on June 6, 2011. Electronic 

comments must adhere to disability 

accessibility guidelines (Section 508 

compliance). 

Dated: May 3, 2011. 

James J. Berger, 

Associate Public Health Advisor for Blood, 

Organ and Tissue Safety. 

[FR Doc. 2011–11128 Filed 5–5–11; 8:45 am] 

BILLING CODE 4150–41–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the Advisory Group on 

Prevention, Health Promotion, and 

Integrative and Public Health 

AGENCY: Department of Health and 

Human Services, Office of the Secretary, 

Office of the Assistant Secretary for 

Health, Office of the Surgeon General of 

the United States Public Health Service. 

ACTION: Notice. 

SUMMARY: In accordance with Section 

10(a) of the Federal Advisory Committee 

Act, Public Law 92–463, as amended (5 

U.S.C. App.), notice is hereby given that 

a web meeting is scheduled to be held 

for the Advisory Group on Prevention, 

Health Promotion, and Integrative and 

Public Health (the ‘‘Advisory Group’’). 

The web meeting will be open to the 

public. Information about the Advisory